NCT07161414
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07161414
Title A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy (ARTEMIDE-subQ)
Acronym ARTEMIDE-subQ
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR | ESP

Facility Status City State Zip Country Details
Research Site RECRUITING Huntersville North Carolina 28078 United States Details
Research Site RECRUITING San Antonio Texas 78229 United States Details
Research Site RECRUITING Fairfax Virginia 22031 United States Details
Research Site NOT_YET_RECRUITING Seoul 03080 South Korea Details
Research Site NOT_YET_RECRUITING Seoul 03722 South Korea Details
Research Site NOT_YET_RECRUITING Barcelona 08035 Spain Details
Research Site NOT_YET_RECRUITING Barcelona 08036 Spain Details
Research Site NOT_YET_RECRUITING Madrid 28027 Spain Details
Research Site NOT_YET_RECRUITING Madrid 28040 Spain Details
Research Site SUSPENDED Newcastle upon Tyne NE7 7DN United Kingdom Details
Research Site SUSPENDED Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field